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AbstrACt
background The mental health impact of the 2014–2016 
Ebola epidemic has been described among survivors, 
family members and healthcare workers, but little is 
known about its impact on the general population of 
affected countries. We assessed symptoms of anxiety, 
depression and post-traumatic stress disorder (PTSD) in 
the general population in Sierra Leone after over a year of 
outbreak response.
Methods We administered a cross-sectional survey 
in July 2015 to a national sample of 3564 consenting 
participants selected through multistaged cluster sampling. 
Symptoms of anxiety and depression were measured by 
Patient Health Questionnaire-4. PTSD symptoms were 
measured by six items from the Impact of Events Scale-
revised. Relationships among Ebola experience, perceived 
Ebola threat and mental health symptoms were examined 
through binary logistic regression.
results Prevalence of any anxiety-depression symptom 
was 48% (95% CI 46.8% to 50.0%), and of any PTSD 
symptom 76% (95% CI 75.0% to 77.8%). In addition, 6% 
(95% CI 5.4% to 7.0%) met the clinical cut-off for anxiety-
depression, 27% (95% CI 25.8% to 28.8%) met levels 
of clinical concern for PTSD and 16% (95% CI 14.7% to 
17.1%) met levels of probable PTSD diagnosis. Factors 
associated with higher reporting of any symptoms in 
bivariate analysis included region of residence, experiences 
with Ebola and perceived Ebola threat. Knowing someone 
quarantined for Ebola was independently associated with 
anxiety-depression (adjusted OR (AOR) 2.3, 95% CI 1.7 
to 2.9) and PTSD (AOR 2.095% CI 1.5 to 2.8) symptoms. 
Perceiving Ebola as a threat was independently associated 
with anxiety-depression (AOR 1.69 95% CI 1.44 to 1.98) 
and PTSD (AOR 1.86 95% CI 1.56 to 2.21) symptoms.
Conclusion Symptoms of PTSD and anxiety-depression 
were common after one year of Ebola response; 
psychosocial support may be needed for people with 
Ebola-related experiences. Preventing, detecting, and 
responding to mental health conditions should be an 
important component of global health security efforts. 
IntroduCtIon
More than 11 300 deaths were attributed to 
the largest recorded outbreak of Ebola virus 
disease (Ebola) between 2014 and 2016, 
Key messages
What is already known about this topic?
 ► Past studies have documented the mental health 
impact of other infectious disease outbreaks 
including after the 2003 severe acute respiratory 
syndrome epidemic and 2009 H1N1 pandemic.
 ► Some prior studies have examined the effects of 
Ebola on directly affected populations such as 
healthcare workers who cared for patients with 
Ebola.
 ► There is limited documentation, however, of the 
mental health impact of the Ebola epidemic at 
the population level.
What are the new findings?
 ► To the best of our knowledge, the assessment was 
the first national survey that examined the impact 
of the devastating Ebola epidemic on population-
level mental health using globally validated scales, 
and conducted after more than a year of ongoing 
transmission of Ebola in the country.
 ► We found that symptoms of PTSD and anxiety-
depression were common after one year of the 
outbreak, especially among those with Ebola-
related experiences. 
 ► Furthermore, we have demonstrated the ability to 
rapidly administer brief mental health screeners at 
the population level to identify factors associated 
with mental health symptomology towards the end 
of an unprecedented infectious disease epidemic.
recommendations for policy
 ► Preventing, detecting and responding to mental 
health conditions should be an important 
component of global health security efforts.
 ► Use of brief mental health screeners during 
outbreak response could increase the ability to 
identify and address the needs of at-risk groups.
 ► So doing could help avert the substantial short-term 
and long-term effects of mental health disorders on 
individual health and on national health systems, 
societies and economies.
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primarily in Sierra Leone, Liberia and Guinea.1 In Sierra 
Leone alone, there were reports of more than 14 100 
Ebola cases, resulting in over 3900 deaths, and more 
than 30 000 individuals were quarantined due to possible 
Ebola exposure.2 Little is known about the epidemic’s 
effects on the mental health of the general population in 
the affected countries.
Numerous studies have examined the mental health 
effects associated with other infectious disease outbreaks 
including the 2003 severe acute respiratory syndrome 
(SARS) epidemic3–12 and 2009 novel influenza A (H1N1) 
pandemic.13–22 The mental health impact of other emer-
gencies, such as bioterrorism, have also been documented 
among survivors.23 Psychological distress, anxiety, depres-
sion and post-traumatic stress disorder (PTSD) have been 
recorded among populations exposed to mass conflict 
and displacement24 including those affected by the civil 
conflict in Sierra Leone between 1992 and 2002.25 26
Known risk factors for anxiety, depression and PTSD—
including experience with ill individuals, perceptions of 
threat, high levels of mortality, food and resource insecu-
rity, stigma and discrimination, and intolerance of uncer-
tainty—may have been experienced by people in Sierra 
Leone during the Ebola epidemic. Adverse mental health 
outcomes could be expected in the general population 
given the magnitude of the epidemic.15 27 High levels of 
distress have been documented among Ebola survivors 
in Guinea and Sierra Leone28 29 and healthcare workers 
(HCWs) in all three affected countries.29 30
There are few mental health resources in Sierra Leone; 
for example, when the Ebola outbreak began, there was 
only one trained psychiatrist for the population of over 
7 million. Assessments of mental health and of risk factors 
for mental illness can support policy efforts to improve 
resources to address mental health and inform how 
resources can be targeted most efficiently—especially in 
the aftermath of a devastating Ebola epidemic.
The Sierra Leone Ministry of Health and Sanitation 
and the US Centers for Disease Control and Prevention 
collaborated with FOCUS 1000 and other stakeholders 
to implement a national, household-based Ebola Knowl-
edge, Attitudes and Practices (KAP) Survey in July 2015. 
The survey assessed respondents’ Ebola-related KAP, 
perceptions of ongoing Ebola threat, Ebola-related 
experiences, and anxiety-depression and PTSD symp-
toms. The present analysis aimed to estimate prevalence 
of mental health symptoms and factors associated with 
having symptoms in the general population.
MetHods
sampling
The national survey employed a multistage cluster 
sampling procedure with primary sampling units selected 
with probability relative to their size. In order to attain 
95% confidence levels and CIs of  ±3% estimates of the 
national population, 3640 individuals were approached 
across the 4 regions and 14 districts of Sierra Leone. 
Using Sierra Leone’s most recent census list (2004) of 
enumeration areas as the sampling frame, 91 enumera-
tion areas were randomly selected across all 14 districts. 
Within each cluster, 20 households were selected using 
systematic random sampling. To generate reliable 
district-level estimates for key districts, we oversampled 
in the three districts still experiencing active Ebola trans-
mission. A weighting factor was applied to each record 
to adjust for the different sample sizes taken in different 
districts. Within each household, the household head 
and another individual (aged between 15 years and 24 
years) or a woman were approached for consent and 
interviewed.
Main outcomes and measures
Survey questions included sociodemographic character-
istics, Ebola experience, perceived Ebola threat, anxie-
ty-depression symptomology and PTSD symptomology 
(Supplementary file 1). Ebola experience variables 
included whether participants knew someone who had 
died from Ebola and whether they knew someone who 
had been quarantined due to Ebola exposure. Partici-
pants whose only reported experience with Ebola-related 
death (1.4%, n=50) or quarantine was related to public 
figures (1.5% of sample, n=55), such as well-known 
medical doctors who died from Ebola, were excluded 
from this analysis. These two variables were also combined 
into a two-level composite item which included: (1) no 
experience with Ebola-related death or quarantine; (2) 
knowing others who had been quarantined or had died 
from Ebola.
Participants’ perceptions of Ebola as a threat were 
measured by four items that asked whether they perceived 
that Ebola was no longer a threat to (1) Sierra Leone; 
(2) their district; (3) their community; and (4) their 
household. Participants responded using 4-point Likert 
Scale items ranging from 1 (strongly agree) to 4 (strongly 
disagree). Responses were further dichotomised into 
‘agree’ and ‘disagree,’ and the scores reversed so that 
higher scores represented more perceived risk. We also 
created a composite score across all four domains with 
1 representing ‘any perceived Ebola threat’ and 0 repre-
senting ‘no perceived Ebola threat.’
Symptoms of anxiety and depression were measured by 
Patient Health Questionnaire-4 (PHQ-4).31 PHQ-4 was 
developed by combining two ultrabrief screeners, the 
PHQ-2 and the Generalised Anxiety Disorder Scale, that 
have been demonstrated to reliably measure depression 
and anxiety symptoms. Participants were asked to report 
their symptoms of depression and anxiety in the past 
2 weeks on a Likert Scale from 0 (not at all) to 3 (nearly 
every day) for a maximum score of 12. The sample was 
further dichotomised into those who expressed any symp-
toms compared with those who did not by creating a new 
composite variable. We also examined the prevalence 
of anxiety and depression using the established clinical 
cut-off total score of 6, which represents the proportion 
of people who would be considered as having clinical 
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levels of depression or anxiety if the screener were used 
for diagnostic purposes.32
Symptoms of PTSD were measured by the Impact of 
Event Scale-6 (IES-6),33 which is a validated, shortened 
version of the full IES-revised (IES-r).34 35 The full scale 
contains 22 items (scored from 0 to 88) with demon-
strated reliability and validity to measure PTSD symptoms 
across different cultures and settings. While IES-r is gener-
ally not used to diagnose PTSD in clinical settings, it is 
widely used for screening at-risk patients with PTSD. The 
IES-6 includes a total of six items—two items from each 
of the three subscales of the measure, namely intrusion, 
hyperarousal and avoidance.33 Participants were asked 
to report their PTSD symptoms in the past 7 days on a 
Likert Scale ranging from 0 (not at all) to 4 (extremely). 
We dichotomised the sample into those who expressed 
any symptoms versus those who did not by creating a new 
composite variable. We evaluated respondents for whom 
PTSD may be a ‘clinical concern’ using an inputted 1.09 
mean item cut-off score (equivalent to 24/88 on IES-r).36 
In addition, we assessed respondents who met ‘probable 
diagnosis’ of PTSD using an inputted 1.5 mean item 
cut-off score (equivalent to 33/88 total score in IES-r).37
data collection
In June 2015, FOCUS 1000 recruited 75 experienced 
data collectors, 25 team supervisors and 4 regional super-
visors. They were trained for a week on overall assessment 
protocols and guidelines, informed consent, safety and 
security precautions, administration of questionnaire, 
and quality control and assurance. The training included 
oral translation of each item into local languages (Krio, 
Mende, Temne and Limba), back translations (orally), 
group discussions of the translations for accuracy in 
meaning, role plays to reflect possible range of responses, 
and group consensus on the final translations to ensure 
consistent and accurate use of each item. In July 2015, 
the trained data collectors used Open Data Kit for digital 
data collection at the household level. Nearly all inter-
views (>90%) were conducted in Krio.
In July 2015, when the Ebola KAP was adminis-
tered, 99% of the cumulative confirmed Ebola cases 
in the country had been reported.38 Control activities 
continued, including provision of prevention messages, 
case detection, contact identification, quarantine and 
monitoring, and management of cases and deaths. Quar-
antine involved 21 days of home-based isolation with 
armed uniformed police dispatched to enforce restric-
tion of movement in and out of the household.39 Quaran-
tined individuals were clinically monitored, and if Ebola 
was suspected, they were transferred to a holding centre 
for testing.
statistical analysis
The data were analysed using SPSS V.22. Statistical 
significance was defined as a two-tailed p-value less than 
0.05. For reliability, internal consistency was assessed by 
calculating Cronbach’s α values. For factorial validity, 
the factor structures of the PHQ-4 and IES-6 scales were 
examined with confirmatory factor analysis (CFA). The 
relationships between demographic variables (gender, 
age, education and region of residence), Ebola experi-
ence, perceived Ebola threat and mental health symp-
toms were examined. Frequencies, proportions, 95% 
CI of proportions, as well as χ2 tests were generated to 
examine the relationships between sample characteris-
tics and mental health symptoms. Univariate and multi-
variate binary logistic regression analyses were conducted 
to examine the relationship between Ebola experience, 
perceived Ebola threat and mental health symptoms. 
We further examined the effect of Ebola experience, 
perceived Ebola threat and interaction between those 
two variables on mental health status by conducting a 
multivariable logistic regression controlling for potential 
confounders. To avoid multicollinearity, only composite 
scores were entered as predictors into the model. Sex, 
age, education and region were included because they 
have been associated with mental health symptoms in 
other studies. Goodness of Fit Index (GFI), Comparative 
Fit Index (CFI) and root mean square error of approx-
imation (RMSEA) were calculated to measure the CFA 
model. Weighted cell count, percentages and ORs with 
95% CIs are presented in the logistic regression tables.
results
sociodemographic characteristics
Of 3640 individuals approached, 3564 (98%) consented 
to participate in the assessment. Sample characteristics 
by mental health symptoms are presented in table 1. 
The median age of respondents was 35 years (SD=15); 
1774 (50%) were male. The sample comprised respond-
ents from all four geographical regions in Sierra Leone: 
798 (22%) from the west, north 1740 (49%), east 471 
(13%) and south 555 (16%). Boosted district samples in 
Kambia and Port Loko, where cases were still being iden-
tified,9 resulted in a larger sample from the North. Of 
all respondents, 37% had no formal education, 20% had 
some primary school education and 43% had secondary 
or higher education.
Nearly a third (31%) of respondents knew at least one 
person who died from Ebola. Similarly, 1165 participants 
(34%) knew at least one person who was quarantined. 
About a quarter (25%) of respondents knew someone 
who died from Ebola and someone who was quarantined. 
Nearly three quarters (72%) of respondents perceived 
an Ebola threat at one or more levels: in Sierra Leone 
(69%), their district (58%), their community (53%) or 
their household (51%).
Prevalence of symptoms
Figure 1 shows 48% (95% CI 46.8% to 50.0%) of 
respondents reported at least one symptom of anxiety 
or depression, with 6% (95% CI 5.4% to 7.0%) meeting 
the clinical cut-off definition. Of all respondents, 76% 
(95% CI 75.0% to 77.8%) reported one or more PTSD 
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symptoms while 27% (95% CI 25.8% to 28.8%) met levels 
of clinical concern for PTSD and 16% (95% CI 14.7% to 
17.1%) met levels of probable PTSD diagnosis. Among 
all respondents, 47% (95% CI 44.2% to 47.4%) reported 
both symptoms of anxiety and depression, and PTSD.
Multivariate analysis
Table 2A,B describes respondents’ experiences with 
Ebola and the association with anxiety and depression 
and PTSD symptoms, controlling for age, gender, region 
and education level. The experience of knowing someone 
who died from Ebola alone was not independently asso-
ciated with anxiety and depression symptoms (adjusted 
OR (AOR) 1.1 95% CI 0.8 to 1.5, p=0.570) but was inde-
pendently associated with PTSD symptoms (AOR 1.5 
95% CI 1.0 to 2.2, p=0.035). Those participants who knew 
someone quarantined due to Ebola exposure alone were 
more likely to report symptoms of anxiety and depres-
sion (AOR 2.3 95% CI 1.7 to 2.9, p<0.001) and PTSD 
(AOR 2.0 95% CI 1.5 to 2.8, p<0.001) than those who 
did not. Respondents who had both experiences (that is, 
they knew at least one person who died from Ebola and 
someone quarantined) were also more likely to report 
symptoms of anxiety and depression (AOR 1.8 95% CI 
1.5 to 2.2, p<0.001) and PTSD (AOR 2.3 95% CI 1.8 to 
2.8, p<0.001) compared with those who did not report 
both. Those with any Ebola experience were more likely 
to report anxiety and depression symptoms than those 
who had no Ebola experience (AOR 1.8 95% CI 1.6 to 
2.0, p<0.001) and were more likely to report PTSD symp-
toms than those with no Ebola experience (AOR 2.01 
95% CI 1.69 to 2.38, p<0.001).
Table 3 presents the relationship between perceived 
Ebola threat and reported symptoms of anxiety and 
depression and PTSD. Respondents who perceived some 
ongoing threat of Ebola were more likely to report symp-
toms of anxiety-depression (AOR 1.69 95% CI 1.44 to 
1.98, p<0.001) and PTSD (AOR 1.86 95% CI 1.56 to 2.21, 
p<0.001) compared with those who did not.
Table 4 presents multivariate analyses of the associa-
tions between Ebola experience and perceived Ebola 
threat and symptoms of anxiety and depression and 
PTSD, adjusting for gender, age, region and education 
levels. Ebola experience and perceived Ebola threat were 
independently associated with anxiety and depression 
symptoms as well as PTSD symptoms. In addition, the 
interaction between Ebola related experience and risk 
perception was independently associated with both anxi-
ety-depression and PTSD symptoms: participants who 
had Ebola experience and also perceived ongoing Ebola 
Figure 1 Prevalence of anxiety-depression and PTSD symptoms—National Knowledge, Attitudes and Practices Survey, 
Sierra Leone, July 2015 (N=3564). PTSD, post-traumatic stress disorder .
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threat were more likely to report symptoms of anxiety-de-
pression (AOR 1·47 95% CI 1·07 to 2·03, p=0.018) and 
PTSD symptoms (AOR 1·44 95% CI 1·0 to 2·07, p=0.049).
dIsCussIon
In a national sample of Sierra Leoneans after more than 
a year of the unprecedented Ebola epidemic, nearly 
half of all respondents reported at least one symptom 
of anxiety or depression and three quarters expressed 
PTSD symptoms. Most respondents reported between 
one and four symptoms. After adjusting for sociodemo-
graphic variables, we found that persons with any level of 
Ebola experience were more likely to report symptoms 
of anxiety-depression and PTSD. Even though expres-
sion of one or more symptoms was widespread among 
our sample, a lower proportion of respondents met the 
clinical cut-off scores for anxiety-depression (5%–7%) 
and probable diagnosis for PTSD (15%–17%). The 
proportion of respondents who exhibited clinical level 
symptoms of anxiety-depression may be considered 
‘lower than expected’ given the magnitude and duration 
of the epidemic, but may also point to a culture of resil-
iency among Sierra Leoneans.40 On the other hand, we 
documented substantial PTSD, which is a public health 
concern that may require targeted mental health inter-
ventions at the individual level and community level for 
those with some personal Ebola experience.
A national assessment of the mental health impact of 
the 2003 SARS epidemic in Taiwan, using a different 
scale than in our current study, found 4% prevalence of 
depression after the epidemic ended.3 Another popu-
lation-based survey in Taiwan revealed 12% prevalence 
of psychiatric morbidity following SARS.9 In Singapore, 
a community-based sample detected that a quarter of 
all respondents had clinical levels of PTSD symptoms.11 
Other mental health assessments with SARS survivors4 8 
and HCWs5 documented similar or higher clinical PTSD 
levels compared with our current assessment. One study 
found that HCWs with a history of mental illness before 
SARS were more likely to report new onset following the 
epidemic.7 In our assessment, we cannot determine how 
past mental health history of PTSD in Sierra Leone, espe-
cially due to the prolonged civil war from 1992 to 2002, 
may have influenced the levels of clinical PTSD concern 
we detected.
Similar to SARS, the 2009 H1N1 pandemic was associ-
ated with psychological distress among the general popu-
lation,13 14 20 family members of hospitalised patients with 
H1N121 and HCWs.18 In some instances, prevalence of 
H1N1-related anxiety was higher among those who 
had greater intolerance of uncertainty.15 17 Additional 
research is required to better understand the relationship 
between intolerance of uncertainty and quarantine expe-
rience during large-scale infectious disease outbreaks. An 
assessment with HCWs in China found that being quar-
antined and having perceived threat of SARS were asso-
ciated with high depressive symptoms several years after Ta
b
le
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the epidemic ended.10 In a separate study, H1N1 quar-
antine experience did not predict elevated PTSD levels 
while dissatisfaction with control measures was a better 
predictor.16
To the best of our knowledge, no prior study has 
assessed the mental health impact of the protracted Ebola 
epidemic at population levels in Sierra Leone, Liberia 
or Guinea. A limited number of studies have examined 
population-level mental health in other African coun-
tries. One such study in a predominantly rural commu-
nity in Ethiopia found that 14% of the population 
expressed clinical levels of mild depressive, anxiety and 
somatic symptoms.41 On the other hand, a wide variety 
of studies have examined anxiety and depression in high-
risk populations in Africa, including  patients with tuber-
culosis in Ethiopia42 and Angola,43 Rwandans who had 
experienced genocide,44 and Nigerian prison inmates.45 
Findings of varying levels of mental health symptomology 
from these studies suggest that further investigations may 
be required to better understand specific mental health 
impact of the Ebola epidemic on directly affected persons 
such as Ebola survivors.
In a systematic review, adverse mental health impact 
has been documented among conflict-affected persons.24 
In Sierra Leone, during protracted civil conflict, expo-
sure to traumatic events was associated with non-specific 
physical ailments.46 High prevalence of traumatic experi-
ences and psychiatric sequelae has also been documented 
among Sierra Leonean refugees.25 Among war affected 
youth in Sierra Leone, social disorder and perceived 
stigma contributed to both externalising and internal-
ising problems.47 Former child soldiers in Sierra Leone 
saw reliable improvement in PTSD symptoms over time, 
suggesting that a supportive environment may encourage 
resilience.48
A key recommendation in previous studies and WHO 
guidance is to integrate mental health into primary 
healthcare services.49 One study found global return 
on investments for scaling up treatment for depression 
and anxiety.50 An example of such effort is in progress in 
Sierra Leone wherein public health nurses are trained to 
screen patients for possible mental health needs.51 The 
WHO Mental Health Gap Action Programme emphasises 
that scaling up mental health services is a joint respon-
sibility that requires collaboration from governments, 
health professionals, donors, civil society, communities 
and families.52
limitations
Although a random national sample was obtained, our 
sample is not necessarily nationally representative. The 
sample had a higher proportion of respondents with 
any education compared with the general population.53 
However, we did not find any association between educa-
tion level and mental health symptoms, suggesting that 
this may not have influenced our findings. We acknowl-
edge the necessity of validating survey instruments 
before using them in a new cultural context. Although 
PHQ-4 and IES-r have been widely used globally,31–37 54 
neither has been validated nor used in Sierra Leone prior 
to this study. We therefore do not know the validity of 
clinical cut-off scores for our sample. To the best of our 
knowledge, PHQ-4 and IES-r (or the shortened form in 
this assessment) have not been used to measure popu-
lation-level symptoms of mental health in any similar 
setting; making it impossible to compare our results to 
similar populations elsewhere. However, we found both 
had acceptable internal reliability and factorial validity. In 
the current survey, the PHQ-4 instrument demonstrated 
acceptable internal reliability (Cronbach’s α=0.78) 
and good factorial validity (GFI=0.999, CFI=0.999, 
RMSEA=0·030). The shortened IES-6 scale used in the 
present study demonstrated acceptable internal relia-
bility (Cronbach’s α=0.78) and good factorial validity 
(GFI=0·998, CFI=0·998, RMSEA=0.023). In addition, the 
national sample was not designed to produce specific 
estimates for directly affected persons such as Ebola survi-
vors, families of Ebola victims and quarantined persons. 
Moreover, there are no baseline/historical data available 
for comparisons. We also did not measure the effects of 
exposure to Sierra Leone’s civil conflict on long-term 
PTSD outcomes on the population prior to Ebola.
ConClusIons
Overall, our findings underscore the feasibility and 
importance of monitoring and addressing mental health 
during public health outbreaks as well as building capacity 
to do so as part of preparedness efforts. Use of brief 
mental health screeners during outbreak response could 
increase the ability to identify and address the needs of 
high-risk groups. We have demonstrated the ability to 
rapidly administer PHQ-4 and IES-6 at a population-level 
to identify factors associated with mental health sympto-
mology towards the end of an unprecedented infectious 
disease epidemic. Preventing, detecting and responding 
to mental health conditions should be an important 
component of global health security efforts.55 56 
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